Pentose Phosphate Pathway and Glutathione System of Red Blood Cells at the Exacerbation of Chronic Cytomegalovirus Infection during Pregnancy

Michael T. Lucenko, PhD, ScD*; Irina A. Andrievskaya, PhD, ScD

Far Eastern Scientific Center of Physiology and Pathology of Respiration, Siberian Branch of Russian Academy of Sciences; Blagoveshchensk, the Russian Federation

*Corresponding author:  Prof.  Michael  T.  Lucenko, PhD,  ScD,  Academician  of  the RAS, Far Eastern Scientific Center of Physiology and Pathology of Respiration of the RAS. Blagoveshchensk, Russia. E-mail:

Published: March 17, 2017.  doi: 10.21103/Article7(1)_OA2


Objective: To determine the peculiarities of PPP function and GS activity in RBCs of pregnant women at 28 to 30 weeks of gestation during the exacerbation of chronic CMV infection (CMVI).
Methods: The study included 50 pregnant women at 28 to 30 weeks of gestation: 25 CMV-seropositive pregnant women (the main group) with CMVI exacerbation and 25 CMV-seronegative pregnant women (the control group). The two groups were matched in age. We determined the activity of G6PD, GR, GP, and the amount of reduced glutathione and NADP; fatty acid peroxide levels in RBCs; the amount of degenerative forms of RBCs; RBC deformation ability; and indicators of the oxygenated form of hemoglobin and 2,3-DPG.
Results: In RBCs of pregnant women with CMVI exacerbation at 28 to 30 weeks of gestation, cytophotometry analysis of blood smears showed a 2.16-times reduction in the intensity of histochemical reaction to G6P (P<0.001), a 3.3-times reduction in the intensity of histochemical reaction to reduced glutathione (P<0.001), and a 3.1-times reduction in the intensity of histochemical reaction to reduced NADP (P<0.001), compared with the control group. There were disorders in functioning and structural equivalence in both the disulfide reductase system and oxidative systems of PPP in RBCs, which was reflected in lower activity of GR and GP, 1.9 times (P<0.001) and 2.5 times (P<0.001), respectively, in the main group. At the same time, the content of 2,3-DPG was 1.24 times more (P<0.001), whereas RBC deformability was 2.25 times less than in the control group.
Conclusion: CMVI exacerbation at 28 to 30 weeks of gestation causes the inhibition of the metabolic activity of the enzymes of PPP and glutathione system, an initiation of membrane destruction oxidative processes that enhance the deformability of RBCs and decrease oxygen metabolism, which creates the risk of anemia and hemic hypoxia in pregnant women.

chronic cytomegalovirus infection ● pregnancy ● red blood cells ● pentose phosphate pathway ● glutathione system

1.Artemchik TA, Germanenko IG, Kleckij SK. Pathomorphological study of placenta in cytomegalovirus infection. Med Zhurnal. 2012;(3):10-3. [Article in Russian].
2.Bharara R, Singh S, Pattnaik P, Chitnis C, Sharma A. Structural analogs of sialic acid interfere with the binding of erythrocyte binding antigen-175 to glycophorin A, an interaction crucial for erythrocyte invasion by Plasmodium falciparum. Mol Biochem Parasitol. 2004;138:123-9.
3.Cowman AF, Crabb BS. Invasion of red blood cells by malaria parasites. Cell. 2006;124(4):755-66.
4.Vorob'ev AI. Manual on Hematology. M.: N'yudiamed; 2007, 1274 p. [In Russian].
5.Lucenko MT, Andrievskaya IA. Patent of the Russian Federation,  “A method for the determination of glutathione in erythrocytes of peripheral blood”. RU № 2526832; register. of 27.08.2014; Bull. № 24. [in Russian].
6.Lucenko MT, Andrievskaya IA. Patent of the Russian Federation, “A method for evaluating the inducing effect of cytomegalovirus infection in the third trimester of gestation on deforming properties of peripheral blood erythrocytes”. RU №. 2546532 register. of 10.04.2015; Bull. № 10. [in Russian].
7.Pokrovskij AA. Biochemical methods of research. M.: Meditsina; 1969, 337 pp. [In Russian].
8.Luganova IS, Blinova MN. Determination of 2,3-phosphoglyceric acid by non-enzymatic method and the content of 2,3-phosphoglycerate and ATP in erythrocytes of patients with chronic lymphocytic leukemia.. Laboratornoe delo. 1975;(6):625-54. [Article in Russian].
9.Salvador A, Savageau MA. Quantitative evolutionary design of glucose-6-phosphote dehydrogenase expression in human erythrocytes. Proc Natl Acad Sci USA. 2003;100(24):14463-8.
10.Vulliam TI, Luzzatto L. Glucose-6-phosphote dehydrogenase deficiency and related disorders. In: Handin RI, Lux SE, Stossel TP (editors). Blood: Principles and practice of hematology. Philadelphia: Lippincott Williams and Wilkins; 2003:1921-50.
11.Kotaka M, Gover S, Vandeputte-Rutten L, Au SW, Lam VM, Adams MJ. Structural studies of glucose-6-phosphote and NADP+ binding to human glucose-6-phosphote dehydrogenase. Acta Crystallogr D Biol Crystallogr. 2005;61(Pt 5):495-504.
12.Cappellini M, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008; 371(9606):64-74. doi: 10.1016/S0140-6736(08)60073-2.
13.Tang HY, Ho HY, Wu PR, Chen SH, Kuypers FA, Cheng ML, Chiu DT. Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal. 2015;22(9):744-59. doi: 10.1089/ars.2014.6142.

The fully formatted PDF version is available.
Download Article
International Journal of Biomedicine. 2017;7(1):32-36. © 2017 International Medical Research and Development Corporation. All rights reserved.